Triclosan: The Antibacterial Chemical FDA Banned From Soap

Evidence Review

Human exposure prevalence

Calafat and colleagues (2008) analyzed 2,517 urine samples collected during the 2003-2004 NHANES cycle, the first nationally representative biomonitoring study to measure triclosan in the United States [3]. Triclosan was detected in 74.6% of samples at concentrations of 2.4-3,790 micrograms per liter, with a geometric mean of 13.0 micrograms per liter and a 95th percentile of 459.0 micrograms per liter. Concentrations were highest in people aged 20-29 and in households in the highest income quartile, an unusual exposure pattern explained by personal care product use rather than occupational exposure. The study established that triclosan exposure was nearly universal in the U.S. population, motivating subsequent investigation of health effects.

Thyroid hormone associations

Koeppe and colleagues (2013) used NHANES 2007-2008 data — 1,831 participants with paired urinary triclosan/paraben measurements and serum thyroid hormone panels — to assess whether biomonitored exposure correlated with thyroid disruption [7]. After adjustment for age, sex, BMI, race, urinary creatinine, and serum cotinine, urinary triclosan was inversely associated with total thyroxine (T4) in adolescents, with stronger effects in girls. The effect size was modest at the population level but supports the mechanistic case from animal studies that triclosan interferes with thyroid hormone homeostasis. Subsequent studies in pregnant women have reported similar associations between triclosan and altered maternal thyroid hormones.

Liver toxicity in animal models

Yueh and colleagues (2014) fed mice a diet containing 0.09% triclosan — chosen to produce serum levels comparable to those measured in humans — for six months [1]. Compared to controls, triclosan-fed mice showed enhanced hepatocyte proliferation, increased markers of fibrosis, oxidative stress, and altered expression of hepatic genes related to xenobiotic metabolism. When the same mice received diethylnitrosamine to initiate hepatocarcinogenesis, triclosan accelerated tumor development: tumors were larger, more numerous, and appeared earlier than in controls. The authors traced the effect to triclosan's activation of constitutive androstane receptor (CAR), a nuclear receptor whose chronic stimulation is known to drive tumor promotion in rodents. Six months in mice corresponds roughly to 18 years of human exposure, raising concerns about cumulative effects given the duration of triclosan use in consumer products.

Effectiveness vs. plain soap

Aiello, Larson, and Levy (2007) systematically reviewed 27 studies comparing antibacterial soap (containing 0.1-0.45% triclosan) to plain soap for two outcomes: bacterial reduction on hands and prevention of infectious illness symptoms [4]. Across community-setting studies, triclosan soaps were not significantly better than plain soap at reducing hand bacterial counts or preventing gastrointestinal and respiratory infections. The same review summarized laboratory evidence that bacteria exposed to sub-lethal triclosan concentrations developed mutations in the FabI enzyme, conferring resistance to triclosan and cross-resistance to several clinically important antibiotics. The combination — no measurable benefit, plausible harm — became the central evidentiary basis for the FDA's 2016 rulemaking.

Pregnancy and birth outcomes

Geer and colleagues (2017) measured triclosan, triclocarban, and five paraben species in third-trimester maternal urine and umbilical cord blood from 185 mothers and 34 paired neonates in Brooklyn, New York (2007-2009) [5]. After adjustment for maternal age, BMI, parity, and gestational diabetes, triclocarban exposure was associated with shorter gestational age at birth, while butylparaben was independently associated with reduced birth weight and increased odds of preterm birth. Triclosan itself did not show statistically significant associations in this cohort, possibly due to limited sample size and high paraben/triclosan correlation. A 2020 meta-analysis pooling later cohorts reported significant inverse associations between maternal triclosan and gestational age, suggesting the Brooklyn study was likely underpowered. Cord blood detection confirms transplacental passage, meaning the fetus is directly exposed during sensitive windows of development.

Regulatory and consensus assessments

The Florence Statement (Halden et al., 2017) is a consensus document signed by more than 200 scientists and medical professionals summarizing the evidence on triclosan and triclocarban [2]. The signatories concluded that both chemicals are environmentally persistent endocrine disruptors that bioaccumulate in aquatic organisms, generate toxic byproducts including dioxins and chlorophenols when degraded, and confer no demonstrated health benefit in consumer products. The statement called for restricting use to applications with documented medical benefit, full ingredient disclosure, and proactive evaluation of replacement chemicals to avoid simply substituting one antimicrobial for another with similar properties. Weatherly and Gosse (2017) reviewed the broader pharmacological evidence in the Annual Review of Pharmacology and Toxicology, summarizing more than 1,700 papers on triclosan's effects on endocrine, immune, microbiome, and reproductive systems [6].

The FDA's 2016 final rule (21 CFR Part 310) determined that triclosan and 18 other antimicrobials were neither generally recognized as safe nor effective for consumer antiseptic washes [8]. The agency cited insufficient long-term safety data, including unresolved questions about endocrine disruption and antibiotic resistance, alongside the absence of demonstrated benefit over plain soap. Manufacturers were given one year to comply, and triclosan was largely removed from U.S. consumer hand and body washes by September 2017. The rule did not address triclosan in toothpaste, healthcare settings, or non-drug products such as textiles, leaving meaningful exposure pathways open.

Strength of evidence

Evidence that triclosan disrupts thyroid and reproductive hormone signaling in laboratory and animal models is strong and mechanistically coherent. Population-level human data show consistent biomonitored exposure and modest but reproducible associations with altered thyroid hormones and pregnancy outcomes. Evidence that triclosan promotes liver tumors in mice is robust; whether the effect translates to humans at typical exposure levels is unresolved but biologically plausible. The evidence that consumer triclosan soaps fail to outperform plain soap is clear and was the formal basis for FDA action. Taken together, the literature supports avoiding triclosan-containing products as a precautionary, low-cost intervention with no opportunity cost — plain soap is equally effective and lacks the endocrine and ecological liabilities.